Skip to main content

Lumexa Imaging Holdings, Inc.

corporate_fare Company Profile

Lumexa Imaging Holdings, Inc.

LMRI·NASDAQ·Industrial Applications And Services·CIK 0002071288

Lumexa Imaging Holdings, Inc. is one of the largest national providers of diagnostic imaging services. As of December 31, 2025, the company and its affiliates operated the second largest outpatient imaging center footprint in the United States, comprising 188 centers across 13 states. This includes eight joint venture partnerships with health systems. The centers are located in metropolitan service areas that experienced an average annual population growth of approximately 1.4% on a center-weighted basis between 2020 and 2024. These centers offer convenient retail settings and extended hours. Lumexa Imaging Holdings, Inc. has a diversified network of approximately 102,000 referring physicians, representing more than 32,000 physician practices in 2025. The company utilizes best-in-class equipment and technology. Magnetic resonance imaging ("MRI") and computed tomography ("CT") referrals were a key driver of revenue growth, accounting for 52% of consolidated revenue and 63% of system-wide revenue for the year ended December 31, 2025. Of the 188 centers operated, 102 were owned by the company's wholly owned subsidiaries and variable interest entities as of December 31, 2025.

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors LMRI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Lumexa Imaging Forms Joint Venture with World-Leading HSS to Expand New York Outpatient Imaging
  • Lumexa Imaging Returns to Profitability in Q1 2026 with $252.5M Revenue, $0.02 EPS
  • Lumexa Imaging Swings to Profitability in Q1 2026, Driven by Reduced Interest Expense and Improved Operating Cash Flow
  • Lumexa Imaging Reports Q1 Profit, Strong EPS Growth, and Strategic Expansion
  • Lumexa Imaging Reports Strong 2025 Financials and IPO-Driven Debt Reduction; Material Weaknesses in Internal Controls Persist
Browse all tickers starting with L →
$9.64
52-week range · as of 2026-05-12 $7.23 – $19.45
Market cap
$926.22M
Volume
663.5K (0.7× avg)
3-mo avg 994.1K
Live data · 2026-06-14 03:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LMRI - Latest Insights

LMRI
Jun 02, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $7.35
Real-time Price: $9.64 info
Change: +$2.29 (+31%) info
Market Cap: $926.218M info
LMRI
May 12, 2026, 4:21 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $10.50
Real-time Price: $9.64 info
Change: -$0.860 (-8%) info
Market Cap: $926.218M info
LMRI
May 12, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.15
Real-time Price: $9.64 info
Change: -$1.51 (-14%) info
Market Cap: $926.218M info
LMRI
May 12, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.50
Real-time Price: $9.64 info
Change: -$0.860 (-8%) info
Market Cap: $926.218M info
LMRI
Mar 30, 2026, 5:32 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $7.97
Real-time Price: $9.64 info
Change: +$1.67 (+21%) info
Market Cap: $926.218M info
LMRI
Mar 26, 2026, 6:09 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.06
Real-time Price: $9.64 info
Change: -$1.42 (-13%) info
Market Cap: $926.218M info
LMRI
Mar 26, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $11.06
Real-time Price: $9.64 info
Change: -$1.42 (-13%) info
Market Cap: $926.218M info
LMRI
Mar 02, 2026, 9:12 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $14.14
Real-time Price: $9.64 info
Change: -$4.50 (-32%) info
Market Cap: $926.218M info
LMRI
Mar 02, 2026, 6:14 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $14.14
Real-time Price: $9.64 info
Change: -$4.50 (-32%) info
Market Cap: $926.218M info